Beech Tree Labs, Inc., specializes in discovery and early-stage development of pharmaceutical formulations that address chronic disorders. Characteristic of a streamlined approach, Beech Tree out-licenses product candidates in order to finalize clinical development en route to market. The Company employs proven, rapid, and inexpensive methods to capitalize on an extensive and ever-growing portfolio of patents covering many potential products.
Based on decades of laboratory research, animal-model studies, and formal clinical trials it is evident that these products and product candidates constitute a platform that addresses a broad spectrum of disorders. This novel therapeutic approach of cellular communication is designated Resonant Molecular Signaling.
The unique characteristics of the various agents in this platform includes:
Beech Tree is an innovative company with attributes that clearly distinguish its prospects for long-term success. Specifically, it has:
Resulting from the experience of its management team and an established professional network, Beech Tree Labs has several product candidates in various stages of development and a robust pipeline.